INSIGHTS ON DRUG DEVELOPMENT

• Matrix Approach Enhances Potency Assay Development For ATMPs

  Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.

• Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis

  Real-time cell health monitoring reveals how drug dose and timing impact apoptosis, necrosis, and viability. Explore how automated workflows help pinpoint mechanistic toxicity windows.

• Use Of Spray Drying In Pharmaceutical Product Development

  Through this detailed exploration, participants will gain valuable knowledge on how to leverage spray drying to optimize drug development and delivery.

• Streamlining 3D Cancer Assays With Automated Innovations

  Gain insight into the use of 3D cultured cancer models in the search for new therapies for complex diseases like cancer.

• Patented Process For Intermediates Useful For Etrasimod Arginine

  3/13/2026

  Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.

• Improve The Performance Of Your Small And Large Molecule Medicines

  7/23/2024

  Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.

• Modifying The Micro-Environment To Improve Dissolution Rate

  6/11/2025

  Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.

• The Future Of Preclinical Animal Models In Drug Discovery

  5/10/2024

  The paradigm shift from animal to human Organ-Chips in preclinical research offers promising insights and efficiencies, crucial for advancing drug development and reducing human suffering.

• How To Confidently Predict Toxicity Of Preclinical Drug Candidates

  8/2/2024

  Incorporating Liver-Chips into preclinical workflows could reduce drug-induced liver injury-related trial failures. Review this quantitative framework for integrating Liver-Chip data into pharmaceutical decision-making.